Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure

This publication has 32 references indexed in Scilit:

• Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy
  American Heart Journal, 1988
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Dilation of Epicardial Arteries in Conscious Dogs Induced by Angiotensin-Converting Enzyme Inhibition with Enalaprilat
  Journal of Cardiovascular Pharmacology, 1987
• A placebo-controlled trial of captopril in refractory chronic congestive heart failure
  Journal of the American College of Cardiology, 1983
• Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure
  The American Journal of Cardiology, 1982
• Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.
  Circulation, 1982
• Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
  Circulation, 1982
• Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
  Circulation, 1982
• Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme
  New England Journal of Medicine, 1979
• Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening.
  Circulation, 1976